Many proposals to modify the Affordable Care Act include eliminating the individual mandate, which remains unpopular, but doing so would have significant effects, according to a RAND analysis.
The Affordable Care Act (ACA)'s provision that requires most American obtain health insurance or pay a penalty, known as the individual mandate, remains unpopular with 64% of respondents to a Kaiser Family Foundation survey saying they view the provision unfavorably. Many proposals to modify the ACA would eliminate the individual mandate.
A new blog post from RAND examines the impact of removing the requirement to buy health insurance, which is a critical component to schieving the law's goal of near-universal health coverage.
"We find that repealing the requirement would significantly reduce health insurance enrollment and cause individual market premiums to rise," wrote Evan Saltzman, a project associate at RAND, and Christine Eibner, a senior economist at the RAND Corporation.
They explain that the purpose of the individual mandate is to provide an incentive for young and healthy people to enroll, which offsets the cost of older or less healthy enrollees. They used RAND's COMPARE model and concluded that based on enrollment prior to the ACA and other facotrs, 12.3 million fewer people would have insurance coverage if the individual mandate were repealed.
Half of those people who would drop coverage without the requirement would come from individual market plans and the remainder would drop coverage acquired through either their employer or Medicaid and the Children's Health Insurance Program. The effect of this drop in enrollment would cause premiums to increase by 8% in 2017 with large losses among the young and the healthy. As a result of the premium increase, Saltzman and Eibner estimate another 2.1 million people would disenroll from the individual market.
"Policymakers seeking to eliminate the individual mandate may need to develop alternative mechanisms for managing costs if they want to avoid these adverse effects," they wrote.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More